BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35535692)

  • 1. Transcriptome of sessile serrated adenoma/polyps is associated with MSI-high colorectal cancer and decreased expression of CDX2.
    Ohki D; Yamamichi N; Sakaguchi Y; Takahashi Y; Kageyama-Yahara N; Yamamichi M; Takeuchi C; Tsuji Y; Sakai Y; Sakurai K; Tomida S; Koike K; Fujishiro M
    Cancer Med; 2022 Dec; 11(24):5066-5078. PubMed ID: 35535692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular features of colorectal hyperplastic polyps and sessile serrated adenoma/polyps from Korea.
    Kim KM; Lee EJ; Ha S; Kang SY; Jang KT; Park CK; Kim JY; Kim YH; Chang DK; Odze RD
    Am J Surg Pathol; 2011 Sep; 35(9):1274-86. PubMed ID: 21836485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of sessile serrated adenoma/polyps with dysplasia/carcinoma based on immunohistochemistry, next-generation sequencing, and microsatellite instability testing: a case series study.
    Murakami T; Akazawa Y; Yatagai N; Hiromoto T; Sasahara N; Saito T; Sakamoto N; Nagahara A; Yao T
    Diagn Pathol; 2018 Nov; 13(1):88. PubMed ID: 30458818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reappraisal of the genetic heterogeneity of sessile serrated adenoma/polyp.
    Cho H; Hashimoto T; Yoshida H; Taniguchi H; Ogawa R; Mori T; Hiraoka N; Saito Y; Sekine S
    Histopathology; 2018 Oct; 73(4):672-680. PubMed ID: 29920740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis?
    Velho S; Moutinho C; Cirnes L; Albuquerque C; Hamelin R; Schmitt F; Carneiro F; Oliveira C; Seruca R
    BMC Cancer; 2008 Sep; 8():255. PubMed ID: 18782444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of "sessile serrated" adenoma to carcinoma transition in six early colorectal cancers.
    Cappellesso R; Lo Mele M; Munari G; Rosa-Rizzotto E; Guido E; De Lazzari F; Pilati P; Tonello M; Farinati F; Realdon S; Fassan M; Rugge M
    Pathol Res Pract; 2019 May; 215(5):957-962. PubMed ID: 30738693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotype and polyp landscape in serrated polyposis syndrome: a series of 100 patients from genetics clinics.
    Rosty C; Buchanan DD; Walsh MD; Pearson SA; Pavluk E; Walters RJ; Clendenning M; Spring KJ; Jenkins MA; Win AK; Hopper JL; Sweet K; Frankel WL; Aronson M; Gallinger S; Goldblatt J; Woodall S; Arnold J; Walker NI; Jass JR; Parry S; Young JP
    Am J Surg Pathol; 2012 Jun; 36(6):876-82. PubMed ID: 22510757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Profiling Based on KRAS/BRAF Mutation, Methylation, and Microsatellite Statuses in Serrated Lesions.
    Sugai T; Eizuka M; Fujita Y; Kawasaki K; Yamamoto E; Ishida K; Yamano H; Suzuki H; Matsumoto T
    Dig Dis Sci; 2018 Oct; 63(10):2626-2638. PubMed ID: 29974407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic diagnosis of sessile serrated adenoma/polyp with and without dysplasia/carcinoma.
    Murakami T; Sakamoto N; Nagahara A
    World J Gastroenterol; 2018 Aug; 24(29):3250-3259. PubMed ID: 30090005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum.
    Kambara T; Simms LA; Whitehall VL; Spring KJ; Wynter CV; Walsh MD; Barker MA; Arnold S; McGivern A; Matsubara N; Tanaka N; Higuchi T; Young J; Jass JR; Leggett BA
    Gut; 2004 Aug; 53(8):1137-44. PubMed ID: 15247181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation.
    Yan HHN; Lai JCW; Ho SL; Leung WK; Law WL; Lee JFY; Chan AKW; Tsui WY; Chan ASY; Lee BCH; Yue SSK; Man AHY; Clevers H; Yuen ST; Leung SY
    Gut; 2017 Sep; 66(9):1645-1656. PubMed ID: 27329244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points.
    O'Brien MJ; Yang S; Mack C; Xu H; Huang CS; Mulcahy E; Amorosino M; Farraye FA
    Am J Surg Pathol; 2006 Dec; 30(12):1491-501. PubMed ID: 17122504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency.
    Dawson H; Galván JA; Helbling M; Muller DE; Karamitopoulou E; Koelzer VH; Economou M; Hammer C; Lugli A; Zlobec I
    Int J Cancer; 2014 May; 134(10):2342-51. PubMed ID: 24166180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The serrated neoplasia pathway of colorectal tumors: Identification of MUC5AC hypomethylation as an early marker of polyps with malignant potential.
    Renaud F; Mariette C; Vincent A; Wacrenier A; Maunoury V; Leclerc J; Coppin L; Crépin M; Van Seuningen I; Leteurtre E; Buisine MP
    Int J Cancer; 2016 Mar; 138(6):1472-81. PubMed ID: 26476272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KRAS and BRAF mutations and MSI status in precursor lesions of colorectal cancer detected by colonoscopy.
    Yamane LS; Scapulatempo-Neto C; Alvarenga L; Oliveira CZ; Berardinelli GN; Almodova E; Cunha TR; Fava G; Colaiacovo W; Melani A; Fregnani JH; Reis RM; Guimarães DP
    Oncol Rep; 2014 Oct; 32(4):1419-26. PubMed ID: 25050586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic and molecular characterization of colorectal sessile serrated adenoma/polyps with cytologic dysplasia.
    Tanaka Y; Yamano HO; Yamamoto E; Matushita HO; Aoki H; Yoshikawa K; Takagi R; Harada E; Nakaoka M; Yoshida Y; Eizuka M; Sugai T; Suzuki H; Nakase H
    Gastrointest Endosc; 2017 Dec; 86(6):1131-1138.e4. PubMed ID: 28501592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling of serrated polyps identifies annexin A10 as a marker of a sessile serrated adenoma/polyp.
    Gonzalo DH; Lai KK; Shadrach B; Goldblum JR; Bennett AE; Downs-Kelly E; Liu X; Henricks W; Patil DT; Carver P; Na J; Gopalan B; Rybicki L; Pai RK
    J Pathol; 2013 Aug; 230(4):420-9. PubMed ID: 23595865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermediate serrated polyp as an intermediate lesion of hyperplastic polyp and sessile serrated polyp/adenoma in terms of morphological and molecular features.
    Kwon HJ; Cho NY; Chang MS; Kim YS; Kang GH
    Hum Pathol; 2014 Aug; 45(8):1759-65. PubMed ID: 24935059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Biomarkers of Sessile Serrated Adenoma/Polyps.
    Kanth P; Boylan KE; Bronner MP; Boucher KM; Hazel MW; Yao R; Pop S; Bernard PS; Delker DA
    Clin Transl Gastroenterol; 2019 Dec; 10(12):e00104. PubMed ID: 31789933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Colorectal serrated adenoma: diagnostic criteria and clinical implications].
    Rüschoff J; Aust D; Hartmann A
    Verh Dtsch Ges Pathol; 2007; 91():119-25. PubMed ID: 18314605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.